SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-15-006481
Filing Date
2015-12-31
Accepted
2015-12-31 11:54:12
Documents
35
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 631571
2 ex31-1.htm EX-31.1 15435
3 ex32-1.htm EX-32.1 7147
  Complete submission text file 0001493152-15-006481.txt   1569287

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ptlf-20140831.xml EX-101.INS 117351
5 XBRL SCHEMA FILE ptlf-20140831.xsd EX-101.SCH 14315
6 XBRL CALCULATION FILE ptlf-20140831_cal.xml EX-101.CAL 19157
7 XBRL DEFINITION FILE ptlf-20140831_def.xml EX-101.DEF 43547
8 XBRL LABEL FILE ptlf-20140831_lab.xml EX-101.LAB 107952
9 XBRL PRESENTATION FILE ptlf-20140831_pre.xml EX-101.PRE 86774
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-52445 | Film No.: 151315440
SIC: 2860 Industrial Organic Chemicals